Longevity Acquisition Corp. (LOAC) relating to its proposed merger with 4D Pharma PLC. Under the terms of the agreement, LOAC shareholders will receive 7.5315 shares of 4D Pharma per share.
Longevity Acquisition Corp. (LOAC) relating to its proposed merger with 4D Pharma PLC. Under the terms of the agreement, LOAC shareholders will receive 7.5315 shares of 4D Pharma per share.